ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Arch Therapeutics Inc

Arch Therapeutics Inc (0HHJ)

0.434
0.00
(0.00%)
Closed January 05 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.434
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
0.434 52 Week Range 0.434
Market Cap
Previous Close
0.434
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
3,094,000
Dividend Yield
-
PE Ratio
-0.09
Earnings Per Share (EPS)
-2.26
Revenue
76k
Net Profit
-6.98M

About Arch Therapeutics Inc

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Carson City, Nevada, USA
Founded
-
Arch Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker 0HHJ. The last closing price for Arch Therapeutics was $0.43. Over the last year, Arch Therapeutics shares have traded in a share price range of $ 0.434 to $ 0.434.

Arch Therapeutics currently has 3,094,000 shares outstanding. The market capitalization of Arch Therapeutics is $1.34 million. Arch Therapeutics has a price to earnings ratio (PE ratio) of -0.09.

0HHJ Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.4340.4340.43400DE
4000.4340.4340.43400DE
12000.4340.4340.43400DE
26000.4340.4340.43400DE
52000.4340.4340.43400DE
156000.4340.4340.43400.434DE
260000.4340.4340.43410.434DE

0HHJ - Frequently Asked Questions (FAQ)

What is the current Arch Therapeutics share price?
The current share price of Arch Therapeutics is $ 0.434
How many Arch Therapeutics shares are in issue?
Arch Therapeutics has 3,094,000 shares in issue
What is the market cap of Arch Therapeutics?
The market capitalisation of Arch Therapeutics is USD 1.34M
What is the 1 year trading range for Arch Therapeutics share price?
Arch Therapeutics has traded in the range of $ 0.434 to $ 0.434 during the past year
What is the PE ratio of Arch Therapeutics?
The price to earnings ratio of Arch Therapeutics is -0.09
What is the cash to sales ratio of Arch Therapeutics?
The cash to sales ratio of Arch Therapeutics is 8.13
What is the reporting currency for Arch Therapeutics?
Arch Therapeutics reports financial results in USD
What is the latest annual turnover for Arch Therapeutics?
The latest annual turnover of Arch Therapeutics is USD 76k
What is the latest annual profit for Arch Therapeutics?
The latest annual profit of Arch Therapeutics is USD -6.98M
What is the registered address of Arch Therapeutics?
The registered address for Arch Therapeutics is 769 BASQUE WAY, SUITE 300, CARSON CITY, NEVADA, 89706
What is the Arch Therapeutics website address?
The website address for Arch Therapeutics is www.archtherapeutics.com
Which industry sector does Arch Therapeutics operate in?
Arch Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
Investor2014 Investor2014 5 minutes ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 11 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 12 minutes ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 16 minutes ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 19 minutes ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 19 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 22 minutes ago
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 25 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 27 minutes ago
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 28 minutes ago
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 29 minutes ago
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 30 minutes ago
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 32 minutes ago
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 46 minutes ago
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 47 minutes ago
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII
Jane1999 Jane1999 47 minutes ago
Here the CEO : https://www.wsj.com/market-data/quotes/CA/XCNQ/TWOH/company-people/executive-profile/149699
TWOH
Curious Bystander Curious Bystander 50 minutes ago
The Expert Market was set up by the SEC for several very specific reasons. But you could generally say that a security lands in that market when a company is either UNABLE or UNWILLING to file certain SEC-required forms.

UNABLE or UNWILLING. Hmmmm…..I wonder which category Quantum
FLCX
CometNebula81 CometNebula81 52 minutes ago
What is everyone's opinion on if or when dividends may be restored and if so what much would we be looking at in dividends? Let's you have 100,000 shares what would you be getting every year?
FNMA
Steady_T Steady_T 52 minutes ago
Wouldn't the MABS have to be better than donepezil and memantine to get approved making them the new SOC?

That doesn't mean the MABS are selling well.
AVXL
mrwhippy458 mrwhippy458 53 minutes ago
Somewhat true. Once it's at 250m OS, they need to bring that market cap up so we can start seeing dollars
ABQQ
CrossFireTrader CrossFireTrader 56 minutes ago
Actually Alocations are given to Dealerships based on how many Vettes they have sold in prior years 25 years ago I lived in Los Angeles and there was a small city Montclair about 10 15 south of Pasadena there was a Dealership there Richard Hibbard Chevrolet and he got more Vettes than anyone in the
GDVM
Roman516 Roman516 59 minutes ago
NWBO stock price manipulation NoGro,

Per your comments,
"NWBO share price dropped 58% i 52 weeks -- That means that longs are SELLING as they don't have confidence in the future of the company. No cash, vulture investors diluting shareholders, no real commercial prospects (UK i
NWBO
WATERFALL1 WATERFALL1 60 minutes ago
GVSI is uptrend stock already

Alligator opened the mouth on Dec.-06-2024
GVSI
StockItOut StockItOut 1 hour ago
you're extrapolating. And youre attempt8ng to place it without understanding the reality of the contract in which its terms act.
XERI

Your Recent History

Delayed Upgrade Clock